These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 330169)

  • 21. [Results of treatment of arterial hypertension using a pindolol preparation].
    Kinczkowska D; Idzińska M; Morawska M; Budniak Z; Weyssenhoff K; Zochowski RJ
    Pol Tyg Lek; 1986 Dec; 41(48):1524-7. PubMed ID: 3295811
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antihypertensive properties of a beta blocking agent, pindolol].
    Safar M; Weiss Y; Sobel A; Lagrue G; Milliez P
    Nouv Presse Med; 1973 Nov; 2(40):2685-8. PubMed ID: 4586561
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of combined use of pindolol and clopamide on the renin-angiotensin-aldosterone system, electrolyte metabolism and kidney function in patients with primary arterial hypertension].
    Wyrzykowski B; Suchecka-Rachoń K
    Pol Arch Med Wewn; 1987; 77(1-2):31-9. PubMed ID: 3079500
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effectiveness of Viskaldix in patients with primary hypertension].
    Cybulska I; Sznajderman M
    Pol Tyg Lek; 1983 Nov; 38(45):1399-401. PubMed ID: 6374634
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of hypertension with a combination of prindolol and clopamide (author's transl)].
    Gábor G; Jávor T; Szám I; Török E
    MMW Munch Med Wochenschr; 1975 Nov; 117(46):1853-6. PubMed ID: 811982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of the treatment with pindolol and clopamide on left-ventricular systolic and diastolic time intervals in patients with moderate primary arterial hypertension].
    Gross-Sawicka E; Wyrzykowski B; Krupa-Wojciechowska B
    Pol Tyg Lek; 1988 Jul; 43(27):885-8. PubMed ID: 3072538
    [No Abstract]   [Full Text] [Related]  

  • 27. [Arterial blood pressure and various biochemical parameters in the blood of patients with idiopathic hypertension treated with Viskaldix].
    Wiecek A; Kargul W; Gasior Z; Grzeszczak W
    Wiad Lek; 1985 Jul; 38(13):912-9. PubMed ID: 4060720
    [No Abstract]   [Full Text] [Related]  

  • 28. Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
    Persson I
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):91-3. PubMed ID: 786690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
    Persson I
    Adv Clin Pharmacol; 1976; 11():1114-8. PubMed ID: 802071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Field study results of a fixed beta blockader-diuretic combination: effect of dosage reduction ("stepping down")].
    Wyrsch J; Bousquet JC
    Schweiz Rundsch Med Prax; 1983 Oct; 72(40):1279-81. PubMed ID: 6647391
    [No Abstract]   [Full Text] [Related]  

  • 31. [Optimal method of the hypotensive treatment of hypertension with diuretics and sodium chloride substitutes].
    Liusov VA; Kharchenko VI; Savenkov PM; Gorbacheva ON; Mart'ianova II
    Kardiologiia; 1985 Oct; 25(10):76-82. PubMed ID: 4087657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect and tolerability of Viskaldix retard in ambulatory hypertensive patients].
    Kredel L
    Med Welt; 1984 Feb; 35(5):156-9. PubMed ID: 6366438
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of arterial hypertension with a combination of pindolol and clopamide in long-term use (personal experience)].
    Sivacki J; Mostovac B; Uchytil R
    Lijec Vjesn; 1984; 106(11-12):509-12. PubMed ID: 6394938
    [No Abstract]   [Full Text] [Related]  

  • 34. [Long-term study of the antihypertensive effect of the pindolol and clopamide combination].
    Padovan GC; Gruppillo P; Masoni C; Tomaini MD
    G Ital Cardiol; 1981; 11(10):1456-9. PubMed ID: 7341315
    [No Abstract]   [Full Text] [Related]  

  • 35. [Duration of action of a fixed beta blocker-diuretic combination. Randomized double-blind study].
    Niederhauser HU
    Schweiz Rundsch Med Prax; 1982 Jun; 71(22):949-54. PubMed ID: 7050962
    [No Abstract]   [Full Text] [Related]  

  • 36. Antihypertensive effects of pindolol.
    Gonasun LM
    Am Heart J; 1982 Aug; 104(2 Pt 2):374-87. PubMed ID: 7048877
    [No Abstract]   [Full Text] [Related]  

  • 37. The addition of Visken to methyldopa therapy in hypertension: a multicentre study.
    Murphy JE
    J Int Med Res; 1976; 4(2):128-31. PubMed ID: 1026542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term Viskaldix therapy in the treatment of hypertensive patients.
    Dudás M; Iványi J
    Ther Hung; 1985; 33(3):152-5. PubMed ID: 3842011
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study of the antihypertensive effect of the preparation VKB-105 (Viskaldix) in arterial hypertension].
    Ivancić R; Goldner V; Jursić M; Uchytil R; Strbo B
    Lijec Vjesn; 1984; 106(11-12):520-2. PubMed ID: 6394941
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pindolol-clopamide combination in the treatment of arterial hypertension. Clinical study].
    Meilhac B; Bloch E; Zannier D; Metzger JP
    Therapie; 1983; 38(3):271-4. PubMed ID: 6612663
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.